Press releases
Read more:
Categories
2020
2020-03-03 13:15
Nanologica Signs Distributor Agreement for the American, Canadian and European Market
Nanologica AB has signed a distribution agreement with American International Chemical LLC (AIC) for the American, Canadian and European market to further...
2019
2019-12-09 15:20
Renewed agreement with crop protection company
Nanologica has renewed the agreement with the crop protection company that during the year has performed field studies based on Nanologica’s formulation...
On Dec 5-6, Nanologica will take part in the inaugural Respiratory Drug Delivery conference in London, UK. The purpose of the conference is to bring together...
2019-11-14 08:22
Nanologica acknowledges World Diabetes Day
Diabetes is a disease affecting more than 400 million people worldwide, a number that is expected to increase to more than 640 million by 2040. In 2015...
Nanologica’s drug delivery platform NLAB Silica™ consists of nanoporous amorphous proprietary silica particles. By loading the API in NLAB...
2019-10-24 09:53
Nouryon Nordic prize winner Dr Sabrina Valetti
Dr Valetti conducted her research on mesoporous silica particles at Nanologica AB during 2014-2016, as recipient of the prestigious Marie Curie Post Doc...
2019-10-17 07:51
Nanologica’s collaboration project prolonged
The agreement between Nanologica and AstraZeneca for the evaluation of Nanologica’s pending patented technology applied to AstraZeneca materials...
English translation NIC-001 is Nanologica’s sublingual formulation of metoclopramide for treating gastroparesis patients. The process for preparing...
After regulatory investigations and an extended market analysis, Nanologica advances the project NIC-001 towards clinical phase IIa. The market analysis...
2019-08-20 12:39
Start of large-scale production of silica
Large-scale production of Nanologica’s silica has now started at the contract manufacturer Sterling Pharma Solutions Ltd. in Newcastle, United Kingdom...